Thareja Suresh, Kokil Ganesh Rajendra, Aggarwal Saurabh, Bhardwaj Tilak Raj, Kumar Manoj
University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India.
Chem Pharm Bull (Tokyo). 2010 Apr;58(4):526-32. doi: 10.1248/cpb.58.526.
Protein tyrosine phosphatase 1B (PTP 1B), a cytosolic PTP involved in down-regulation of receptor tyrosine kinase activity following stimulation of the insulin or leptin receptors. Thus, PTP 1B inhibitors could potentially ameliorate insulin resistance and normalize plasma glucose and insulin levels without inducing hypoglycemia, and could therefore be a major advancement in the treatment of type 2 diabetes. A three-dimensional quantitative structure-activity relationship (3D-QSAR) study has been performed on a novel class of sulphonamides using self-organizing molecular field analysis (SOMFA) to correlate their chemical structures with their observed PTP 1B inhibitory activities. The master grid obtained for the various SOMFA models indicates electrostatic and shape potential contributions that can be mapped back onto structural features relating to the trends in inhibitory activities. On the basis of the spatial arrangement, steric and electrostatic factors should appropriately be taken into account for development of new potent inhibitors of PTP 1B for the management of type 2 diabetes.
蛋白酪氨酸磷酸酶1B(PTP 1B)是一种胞质磷酸酶,参与胰岛素或瘦素受体刺激后受体酪氨酸激酶活性的下调。因此,PTP 1B抑制剂可能改善胰岛素抵抗,使血糖和胰岛素水平正常化而不引起低血糖,因此可能成为2型糖尿病治疗的重大进展。已使用自组织分子场分析(SOMFA)对一类新型磺酰胺进行了三维定量构效关系(3D-QSAR)研究,以将其化学结构与其观察到的PTP 1B抑制活性相关联。为各种SOMFA模型获得的主网格表明了静电和形状势能贡献,这些贡献可以映射回与抑制活性趋势相关的结构特征。基于空间排列,在开发用于治疗2型糖尿病的新型强效PTP 1B抑制剂时,应适当考虑空间和静电因素。